9/28/2021 1:06:23 AM
Valneva, Pfizer Announce Further Positive Phase 2 Results For Lyme Disease Vaccine Candidate VLA15
9/23/2021 1:08:04 AM
Valneva Begins Recruitment Of Adolescents In Phase 3 Trial For Inactivated COVID-19 Vaccine Candidate VLA2001 In U.K.
9/14/2021 1:04:10 AM
Valneva Completes Recruitment Of Elderly Participants In Phase 3 Trial Of Inactivated COVID-19 Vaccine
9/3/2021 1:04:00 AM
Valneva Announces U.S. DoD Exercises First Year Option On IXIARO Supply Contract
8/10/2021 1:25:59 AM
Valneva H1 Net Loss EUR 86.4 Mln Vs Loss EUR 25.6 Mln Prior Year